Abstract

Research Article

Human Performance Augmenting Drugs and Technologies

R Dinesh Kumar*

Published: 19 November, 2024 | Volume 8 - Issue 1 | Pages: 089-103

In many sectors, ranging from sports and military operations to professional settings (notably cognitive enhancement); human performance augmentation has been an enduring ambition. The idea behind this movement, known as human enhancement, has evolved over time from simple means of training to the improvement or augmentation of physical ability through recent developments in fields such as pharmaceuticals and implantable devices that can enhance natural abilities. They span from pharmaceutical agents to wearable technologies used for sophisticated self-experimentation, which offer promise but also present ethical, health, and societal risks Performance-Enhancing Drugs are used to enhance the performance of humans in one way or another as a basic idea. The categories of Performance Enhancing Drugs (PEDs) included are Stimulants: Stimulant drugs, including amphetamines and caffeine (in the form of coffee) have been used for thousands of endeavours and physical stamina for decades. There have been many sources of controversy in the sporting world due to use or misuse and side-effectual restrictions. The release of neurotransmitters such as dopamine and allowing muscles to grow big, and fast. Nevertheless, the consumption of anabolic steroids is strictly controlled because it has side effects and complications such as liver damage, hormonal imbalances, and greater aggression. Erythropoietin EPO is a hormone that produces red blood cells, and increased oxygen delivery to muscle. EPO Athletes and even more notably endurance athletes (such as cyclists) have a storied history of abusing this performance-enhancing agent to build stamina. However, the misuse of this drug can be very hazardous, as it causes complications such as blood clotting and heart issues.

Read Full Article HTML DOI: 10.29328/journal.jfsr.1001069 Cite this Article Read Full Article PDF

Keywords:

Human enhancement; Performance; Enhancing Drugs (PEDs); Stimulants; Anabolic steroids; Erythropoietin (EPO)

References

  1. Valeriani D, Cecotti H, Thelen A, Herff C. Editorial: Translational brain-computer interfaces: From research labs to the market and back. Available from: https://www.frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2023.1152466/full
  2. McArdle WD, Katch FI, Katch VL. Exercise physiology: nutrition, energy, and human performance. Lippincott Williams & Wilkins; 2010; 1104.
  3. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513-54. Available from: https://doi.org/10.2165/00007256-200434080-00003
  4. Spriet LL. Exercise and sport performance with low doses of caffeine. Sports Med. 2014 Nov;44 Suppl 2(Suppl 2):S175-84. Available from: https://doi.org/10.1007/s40279-014-0257-8
  5. Wells DJ. Gene doping: the hype and the reality. Br J Pharmacol. 2008;154(3):623-31. Available from: https://doi.org/10.1038/bjp.2008.144
  6. Battleday RM, Brem AK. Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review. Eur Neuropsychopharmacol. 2015;25(11):1865-81. Available from: https://doi.org/10.1016/j.euroneuro.2015.07.028
  7. Kay M. Stanney. Augmenting Human Performance, in Neuroadaptive Systems. 2013. Available from: https://www.taylorfrancis.com/chapters/edit/10.1201/b13019-13/augmenting-human-performance-kay-stanney
  8. Roco MC, Bainbridge WS. editors. Converging technologies for improving human performance. 2003. Available from: https://link.springer.com/book/10.1007/978-94-017-0359-8
  9. Barresi G, Ayaz H, Seigneur JM, Di Pino G, Bertolaso M. Editorial: Augmenting human experience and performance through interaction technologies. 2024;15. Available from: https://doi.org/10.3389/fpsyg.2024.1356658
  10. Ryan BJ, Charkoudian N, Joyner MJ. Human performance augmentation: the importance of integrative physiological quantification. J Physiol. 2023;601(3):407-416. Available from: https://doi.org/10.1113/jp283975
  11. Raisamo R, Rakkolainen I, Majaranta P, Salminen K, Rantala J, Farooq A. Human augmentation: Past, present and future. International Journal of Human-Computer Studies. 2019; 131:131-143. Available from: https://www.sciencedirect.com/science/article/pii/S1071581919300576
  12. Opris I, A. Lebedev M, F. Casanova M, editors. Modern approaches to augmentation of brain. 2021; 57-89. Available from: https://psycnet.apa.org/doi/10.1007/978-3-030-54564-2_4
  13. Cinel C, Valeriani D, Poli R. Neurotechnologies for Human Cognitive Augmentation: Current State of the Art and Future Prospects. Front Hum Neurosci. 2019;13:13. Available from: https://doi.org/10.3389/fnhum.2019.00013
  14. Canton J. Designing the future: NBIC technologies and human performance enhancement. Ann N Y Acad Sci. 2004;1013:186-98. Available from: https://doi.org/10.1196/annals.1305.010
  15. Klich J. Human enhancement technologies and healthcare policy. Taylor & Francis; 2024; 83. Available from: https://doi.org/10.4324/9781003449584
  16. Papagiannis, Helen. Augmented human: How technology is shaping the new reality. O'Reilly Media, Inc.", 2017. Available from: https://www.google.co.in/books/edition/Augmented_Human/_L4SswEACAAJ?hl=en
  17. Ola DE, Legg-Jack DW. Human abilities augmentation with intelligent technologies and pervasive computing emerging trends. Available from: https://www.igi-global.com/chapter/human-abilities-augmentation-with-intelligent-technologies-and-pervasive-computing-emerging-trends/318295
  18. Pitsiladis YP. Vision enhancement technologies, augmented reality and sports integrity considerations. BMJ Open Sport Exerc Med. 2023;9(3):e001651. Available from: https://doi.org/10.1136/bmjsem-2023-001651
  19. Villa S, Niess J, Schmidt A, Welsch R. Society’s attitudes towards human augmentation and performance enhancement technologies.2023;128:1-23. Available from: https://dl.acm.org/doi/10.1145/3610915
  20. Marois A, Lafond D. Augmenting cognitive work: a review of cognitive enhancement methods and applications for operational domains.2022; 24(4):589-608. Available from: https://doi.org/10.1007/s10111-022-00715-1
  21. Yoon Y, Cho IJ. A review of human augmentation and individual combat capability: focusing on MEMS-based neurotechnology. Micro and Nano Syst Lett. 2024. Available from: https://doi.org/10.1186/s40486-024-00205-1
  22. Couper FJ, Logan BK. Drugs and human performance fact sheets. 2004. Available from: https://rosap.ntl.bts.gov/view/dot/1759
  23. Stanney KM, Hale KS. Today’s competitive objective: augmenting human performance. In: Schmorrow DD, Fidopiastis CM, editors. Foundations of Augmented Cognition Directing the Future of Adaptive Systems. 2011; 628-635. Available from: https://link.springer.com/chapter/10.1007/978-3-642-21852-1_72
  24. Săvulescu J. The future of human enhancement and setting rules for technological doping. Annals of the University of Bucharest. Available from: https://www.weh.ox.ac.uk/publications/1224954
  25. United Nations : World Drug Report 2020 [Internet]. [cited 2024 Nov 16]. World drug report 2020. Available from: https://wdr.unodc.org/wdr2020/en/index2020.html
  26. Villa S, Kosch T, Grelka F, Schmidt A, Welsch R. The placebo effect of human augmentation: Anticipating cognitive augmentation increases risk-taking behavior.2020; 20:10-21. Available from: https://www.sciencedirect.com/science/article/pii/S0747563223001383
  27. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence.2019; 25:44-56. Available from: https://www.nature.com/articles/s41591-018-0300-7
  28. Gamboa H. Human augmentation: a system engineering conceptual framework. 2021. Available from: https://repository.rit.edu/theses/11679
  29. Jain MP. Indian constitutional law (In 2 Volumes). 2022.
  30. Lakshmi R, Lakshmi R. Case Summary: Justice K. S. Puttaswamy (Retd.) vs. Union of India, 2017. LawLex.Org. 2020. Available from: https://lawlex.org/lex-bulletin/case-summary-k-s-puttaswamy-retd-v-s-union-of-india-2017/18929
  31. Wickens CD, Helton WS, Hollands JG, Banbury S. Engineering psychology and human performance. 5th ed. New York: Routledge; 2021; 596.
  32. Testbook Narcotic drug & psychotropic substances act 1985: features & more | upsc notes. Available from: https://testbook.com/ias-preparation/ndps-act
  33. Health ministry notifies medical devices rules. 2017. Available from:https://pib.gov.in/newsite/printrelease.aspx?relid=157955
  34. Virtual reality and augmented reality on human performance – proquest. 2021. Available from: https://scholarbank.nus.edu.sg/handle/10635/195573
  35. McArdle WD, Katch FI, Katch VL. Exercise physiology: nutrition, energy, and human performance. Lippincott Williams & Wilkins; 2010; 1104. Available from: https://www.google.co.in/books/edition/Exercise_Physiology/XOyjZX0Wxw4C?hl=en
  36. John AR. Real-time mental workload detection and alert system with brain computer interface for augmenting human performance at work. 2023. Available from: https://opus.lib.uts.edu.au/handle/10453/177141
  37. Shneiderman B. Human-centered artificial intelligence: reliable, safe & trustworthy. International Journal of Human. 2020; 495-504. Available from: https://www.tandfonline.com/doi/full/10.1080/10447318.2020.1741118
  38. Martindale VE. Implications of “technology horizons.” Aviation, Space, and Environmental Medicine. 2011 Jan 1;82(1):70–1. Available from: https://www.ingentaconnect.com/contentone/asma/asem/2011/00000082/00000001/art00017?crawler=true&mimetype=application/pdf
  39. Line-storm: an interactive augmented stylus and writing pad for creative human performance. 2018. Available from: https://www.proquest.com/openview/7be62ba7161d135029ed8d1402972550/1?pq-origsite=gscholar&cbl=18750
  40. Kaber DB, Endsley MR. The effects of level of automation and adaptive automation on human performance. 2007; 113-153. Available from: http://www.tandfonline.com/doi/abs/10.1080/1463922021000054335
  41. Stone MO, Blackhurst J, Gresham J, Dahm WJA. Development of the quantified human. In: Artemiadis P, editor. Neuro-Robotics. 2014; 181-205. Available from: https://doi.org/10.1007/978-94-017-8932-5_7
  42. Effects of augmented reality based object illumination on human performance. Available from: https://drum.lib.umd.edu/items/7836a91f-7ba5-4c7f-bd96-d135f9da3995/full
  43. Madeleine P, Eisenhardt D, Kristiansen MV. Identifying the advantages and limitations of sports performance when using augmented reality: 2023; 397. Available from: https://sponet.fi/Record/4086071
  44. Cheung HC, De Louche C, Komorowski M. Artificial Intelligence Applications in Space Medicine. Aerosp Med Hum Perform. 2023;94(8):610-622. Available from: https://doi.org/10.3357/amhp.6178.2023
  45. Augmenting human performance in teleoperation tasks. 2000; 153. Available from: https://dl.acm.org/doi/10.5555/932980
  46. Bienefeld N, Keller E, Grote G. Human-ai teaming in critical care: a comparative analysis of data scientists’ and clinicians’ perspectives on ai augmentation and automation. 2024;26. Available from: https://www.jmir.org/2024/1/e50130
  47. Pratt JE, Krupp BT, Morse CJ, Collins SH. The RoboKnee: an exoskeleton for enhancing strength and endurance during walking. 2004;3:2430-2435. Available from: https://ieeexplore.ieee.org/abstract/document/1307425/
  48. Mintz Y, Brodie R. Introduction to artificial intelligence in medicine. Minimally Invasive Therapy & Allied Technologies.2019;73-81. Available from: https://www.tandfonline.com/doi/full/10.1080/13645706.2019.1575882
  49. Parasuraman R, Galster S. Sensing, assessing, and augmenting threat detection: behavioral, neuroimaging, and brain stimulation evidence for the critical role of attention. Hum. Neurosci. 2013; 7. Available from: https://www.frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2013.00273/full
  50. Gasmi A, Benlamri R. Chapter 4 - Augmented reality, virtual reality and new age technologies demand escalates amid COVID-19. Novel AI and Data Science Advancements for Sustainability in the Era of COVID-19. 2022:89–111. Available from: https://www.sciencedirect.com/science/article/pii/B9780323900546000052
  51. McKinley RA, Bridges N, Walters CM, Nelson J. Modulating the brain at work using noninvasive transcranial stimulation. 2012; 59(10):129-137. Available from: https://www.sciencedirect.com/science/article/pii/S1053811911008706
  52. Carmigniani J, Furht B, Anisetti M, Ceravolo P, Damiani E, Ivkovic M. Augmented reality technologies, systems and applications. Multimedia Tools and Applications. 2010; 51: 341–377. Available from: https://doi.org/10.1007/s11042-010-0660-6
  53. Raisch S, Krakowski S. Artificial intelligence and management: the automation–augmentation paradox. Academy of Management Review. 2020. Available from: http://journals.aom.org/doi/10.5465/amr.2018.0072
  54. Gan CGE. Reconditioning human: alternative functionality in prosthetic augmentation. 2023. Available from: https://dr.ntu.edu.sg/handle/10356/168103
  55. Johnson PC, Laurell C, Ots M, Sandström C. Digital innovation and the effects of artificial intelligence on firms’ research and development – Automation or augmentation. 2016;95: 1-9. Available from: https://www.sciencedirect.com/science/article/pii/S0040162522001688
  56. Onnasch L, Wickens CD, Li H, Manzey D. Human performance consequences of stages and levels of automation.2013. Available from: https://journals.sagepub.com/doi/10.1177/0018720813501549
  57. Pell SJ. Augmented astronaut survival: updating the ‘how to survive on the moon’ scenario workshop in preparation for an artemis edition. 2024;331–41. Available from: https://dl.acm.org/doi/10.1145/3652920.3654916
  58. Kapalo KA, Misewicz JL, Bonnell J. First on scene: practitioner considerations for using augmented and virtual reality for recognizing and treating anaphylaxis. Available from: https://ieeexplore.ieee.org/abstract/document/10322175/
  59. Khushf G. Stage two enhancements. In: Jotterand F, editor. Emerging Conceptual, Ethical and Policy Issues in Bionanotechnology. 2008; 101:203-218. Available from: https://doi.org/10.1007/978-1-4020-8649-6_12

Figures:

Similar Articles

Recently Viewed

  • Pattern of Eye Disease in Nenwe Rural Eye Clinic, Nigeria: A Seven Year Review
    Nnenna Maureen Ozioko*, Nkiru Mary Okoloagu, Emmanuel Sunday Onah and Catherine Nnenna Maureen Ozioko*, Nkiru Mary Okoloagu, Emmanuel Sunday Onah, Catherine. Pattern of Eye Disease in Nenwe Rural Eye Clinic, Nigeria: A Seven Year Review. Int J Clin Exp Ophthalmol. 2024: doi: 10.29328/journal.ijceo.1001056; 8: 004-015
  • Retinopathy of prematurity - Intersibling divergence of risk factors among twins
    Sudeep Navule Siddappa*, Kavitha Chikknayakanahalli Venugopal, Pavana Acharya and Tintu Susan Joy Sudeep Navule Siddappa*,Kavitha Chikknayakanahalli Venugopal,Pavana Acharya ,Tintu Susan Joy . Retinopathy of prematurity - Intersibling divergence of risk factors among twins. Int J Clin Exp Ophthalmol. 2020: doi: 10.29328/journal.ijceo.1001026; 4: 009-011
  • Effectiveness of levocetirizine in treating allergic rhinitis while retaining work efficiency
    Dabholkar Yogesh, Shah Tanush, Rathod Roheet, Paspulate Akhila, Veligandla Krishna Chaitanya, Rathod Rahul, Devesh Kumar Joshi* and Kotak Bhavesh Dabholkar Yogesh, Shah Tanush, Rathod Roheet, Paspulate Akhila, Veligandla Krishna Chaitanya, Rathod Rahul, Devesh Kumar Joshi*, Kotak Bhavesh. Effectiveness of levocetirizine in treating allergic rhinitis while retaining work efficiency. Arch Asthma Allergy Immunol. 2023: doi: 10.29328/journal.aaai.1001031; 7: 005-011
  • Hepatic Pseudolymphoma Mimicking Neoplasia in Primary Biliary Cholangitis: A Case Report
    Jeremy Hassoun, Aurélie Bornand, Alexis Ricoeur, Giulia Magini, Nicolas Goossens and Laurent Spahr* Jeremy Hassoun,Aurélie Bornand,Alexis Ricoeur,Giulia Magini,Nicolas Goossens,Laurent Spahr*. Hepatic Pseudolymphoma Mimicking Neoplasia in Primary Biliary Cholangitis: A Case Report. Arch Case Rep. 2024: doi: 10.29328/journal.acr.1001115; 8: 152-155
  • Other Applications of Amniotic Membranes: Case Series
    Linda Guerrero* Linda Guerrero*. Other Applications of Amniotic Membranes: Case Series. Arch Case Rep. 2024: doi: 10.29328/journal.acr.1001117; 8: 159-162

Read More

Most Viewed

Read More

Help ?